# A Study of Tadalafil in Benign Prostatic Hyperplasia

> **NCT01183650** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 24 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT01183650
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183650, "A Study of Tadalafil in Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01183650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*